Skip to main content

“These exercises of warrants remove almost the entire overhang on the share represented by these instruments that were necessary to obtain the financing to re-acquire the North American rights for RUCONEST®”

- Sijmen de Vries, Pharming’s CEO
Cookies: This website uses cookies Check the cookies page for more information Accept Decline